ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rubella Diagnostic Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22Z2172
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rubella Diagnostic Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Rubella Diagnostic Testing Market Research Report 2025

Code: QYRE-Auto-22Z2172
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
Mayo Clinic
Ortho Clinical Diagnostics
True Health
GlaxoSmithKline
GlaxoSmithKline PLC
HealthLink BC

Rubella Diagnostic Testing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rubella Diagnostic Testing Market

Rubella Diagnostic Testing Market

The global market for Rubella Diagnostic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rubella Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella Diagnostic Testing.
The Rubella Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rubella Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rubella Diagnostic Testing Market Report

Report Metric Details
Report Name Rubella Diagnostic Testing Market
CAGR 5%
Segment by Type
  • Flow Cytometry
  • Latex Slide Agglutination Test
  • Monoclonal Antibodies
  • Immunoassays
  • Serological Testing
  • Clinical Evaluation
Segment by Application
  • Hospitals
  • Commercial
  • Physician Offices
  • Public Health Labs
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Beckman Coulter, Bio Rad Laboratories, Biogate Laboratories, BioMerieux SA, Cigna, Diagnostic Laboratory of Oklahoma, GlaxoSmithKline, HealthLink BC, Mayo Clinic, Ortho Clinical Diagnostics, True Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rubella Diagnostic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rubella Diagnostic Testing Market report?

Ans: The main players in the Rubella Diagnostic Testing Market are Abbott Laboratories, Beckman Coulter, Bio Rad Laboratories, Biogate Laboratories, BioMerieux SA, Cigna, Diagnostic Laboratory of Oklahoma, GlaxoSmithKline, HealthLink BC, Mayo Clinic, Ortho Clinical Diagnostics, True Health

What are the Application segmentation covered in the Rubella Diagnostic Testing Market report?

Ans: The Applications covered in the Rubella Diagnostic Testing Market report are Hospitals, Commercial, Physician Offices, Public Health Labs, Other

What are the Type segmentation covered in the Rubella Diagnostic Testing Market report?

Ans: The Types covered in the Rubella Diagnostic Testing Market report are Flow Cytometry, Latex Slide Agglutination Test, Monoclonal Antibodies, Immunoassays, Serological Testing, Clinical Evaluation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Flow Cytometry
1.2.3 Latex Slide Agglutination Test
1.2.4 Monoclonal Antibodies
1.2.5 Immunoassays
1.2.6 Serological Testing
1.2.7 Clinical Evaluation
1.3 Market by Application
1.3.1 Global Rubella Diagnostic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Commercial
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Diagnostic Testing Market Perspective (2020-2031)
2.2 Global Rubella Diagnostic Testing Growth Trends by Region
2.2.1 Global Rubella Diagnostic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rubella Diagnostic Testing Historic Market Size by Region (2020-2025)
2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Region (2026-2031)
2.3 Rubella Diagnostic Testing Market Dynamics
2.3.1 Rubella Diagnostic Testing Industry Trends
2.3.2 Rubella Diagnostic Testing Market Drivers
2.3.3 Rubella Diagnostic Testing Market Challenges
2.3.4 Rubella Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Diagnostic Testing Players by Revenue
3.1.1 Global Top Rubella Diagnostic Testing Players by Revenue (2020-2025)
3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rubella Diagnostic Testing Revenue
3.4 Global Rubella Diagnostic Testing Market Concentration Ratio
3.4.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2024
3.5 Global Key Players of Rubella Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Rubella Diagnostic Testing, Product and Application
3.7 Global Key Players of Rubella Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Diagnostic Testing Breakdown Data by Type
4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2020-2025)
4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2026-2031)
5 Rubella Diagnostic Testing Breakdown Data by Application
5.1 Global Rubella Diagnostic Testing Historic Market Size by Application (2020-2025)
5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rubella Diagnostic Testing Market Size (2020-2031)
6.2 North America Rubella Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rubella Diagnostic Testing Market Size by Country (2020-2025)
6.4 North America Rubella Diagnostic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rubella Diagnostic Testing Market Size (2020-2031)
7.2 Europe Rubella Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rubella Diagnostic Testing Market Size by Country (2020-2025)
7.4 Europe Rubella Diagnostic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rubella Diagnostic Testing Market Size (2020-2031)
8.2 Asia-Pacific Rubella Diagnostic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rubella Diagnostic Testing Market Size (2020-2031)
9.2 Latin America Rubella Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rubella Diagnostic Testing Market Size by Country (2020-2025)
9.4 Latin America Rubella Diagnostic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Diagnostic Testing Market Size (2020-2031)
10.2 Middle East & Africa Rubella Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
11.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.2.5 Beckman Coulter Recent Development
11.3 Bio Rad Laboratories
11.3.1 Bio Rad Laboratories Company Details
11.3.2 Bio Rad Laboratories Business Overview
11.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
11.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.3.5 Bio Rad Laboratories Recent Development
11.4 Biogate Laboratories
11.4.1 Biogate Laboratories Company Details
11.4.2 Biogate Laboratories Business Overview
11.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
11.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.4.5 Biogate Laboratories Recent Development
11.5 BioMerieux SA
11.5.1 BioMerieux SA Company Details
11.5.2 BioMerieux SA Business Overview
11.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
11.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.5.5 BioMerieux SA Recent Development
11.6 Cigna
11.6.1 Cigna Company Details
11.6.2 Cigna Business Overview
11.6.3 Cigna Rubella Diagnostic Testing Introduction
11.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.6.5 Cigna Recent Development
11.7 Diagnostic Laboratory of Oklahoma
11.7.1 Diagnostic Laboratory of Oklahoma Company Details
11.7.2 Diagnostic Laboratory of Oklahoma Business Overview
11.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
11.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.7.5 Diagnostic Laboratory of Oklahoma Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
11.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 HealthLink BC
11.9.1 HealthLink BC Company Details
11.9.2 HealthLink BC Business Overview
11.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
11.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.9.5 HealthLink BC Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
11.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.10.5 Mayo Clinic Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 True Health
11.12.1 True Health Company Details
11.12.2 True Health Business Overview
11.12.3 True Health Rubella Diagnostic Testing Introduction
11.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2020-2025)
11.12.5 True Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
Mayo Clinic
Ortho Clinical Diagnostics
True Health
GlaxoSmithKline
GlaxoSmithKline PLC
HealthLink BC
List of Tables
 Table 1. Global Rubella Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Flow Cytometry
 Table 3. Key Players of Latex Slide Agglutination Test
 Table 4. Key Players of Monoclonal Antibodies
 Table 5. Key Players of Immunoassays
 Table 6. Key Players of Serological Testing
 Table 7. Key Players of Clinical Evaluation
 Table 8. Global Rubella Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Rubella Diagnostic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Rubella Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Rubella Diagnostic Testing Market Share by Region (2020-2025)
 Table 12. Global Rubella Diagnostic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Rubella Diagnostic Testing Market Share by Region (2026-2031)
 Table 14. Rubella Diagnostic Testing Market Trends
 Table 15. Rubella Diagnostic Testing Market Drivers
 Table 16. Rubella Diagnostic Testing Market Challenges
 Table 17. Rubella Diagnostic Testing Market Restraints
 Table 18. Global Rubella Diagnostic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Rubella Diagnostic Testing Market Share by Players (2020-2025)
 Table 20. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2024)
 Table 21. Ranking of Global Top Rubella Diagnostic Testing Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Rubella Diagnostic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Rubella Diagnostic Testing, Headquarters and Area Served
 Table 24. Global Key Players of Rubella Diagnostic Testing, Product and Application
 Table 25. Global Key Players of Rubella Diagnostic Testing, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Rubella Diagnostic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Rubella Diagnostic Testing Revenue Market Share by Type (2020-2025)
 Table 29. Global Rubella Diagnostic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Rubella Diagnostic Testing Revenue Market Share by Type (2026-2031)
 Table 31. Global Rubella Diagnostic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Rubella Diagnostic Testing Revenue Market Share by Application (2020-2025)
 Table 33. Global Rubella Diagnostic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Rubella Diagnostic Testing Revenue Market Share by Application (2026-2031)
 Table 35. North America Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Rubella Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Rubella Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Rubella Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Rubella Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Rubella Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Rubella Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Rubella Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Abbott Laboratories Company Details
 Table 51. Abbott Laboratories Business Overview
 Table 52. Abbott Laboratories Rubella Diagnostic Testing Product
 Table 53. Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 54. Abbott Laboratories Recent Development
 Table 55. Beckman Coulter Company Details
 Table 56. Beckman Coulter Business Overview
 Table 57. Beckman Coulter Rubella Diagnostic Testing Product
 Table 58. Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 59. Beckman Coulter Recent Development
 Table 60. Bio Rad Laboratories Company Details
 Table 61. Bio Rad Laboratories Business Overview
 Table 62. Bio Rad Laboratories Rubella Diagnostic Testing Product
 Table 63. Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 64. Bio Rad Laboratories Recent Development
 Table 65. Biogate Laboratories Company Details
 Table 66. Biogate Laboratories Business Overview
 Table 67. Biogate Laboratories Rubella Diagnostic Testing Product
 Table 68. Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 69. Biogate Laboratories Recent Development
 Table 70. BioMerieux SA Company Details
 Table 71. BioMerieux SA Business Overview
 Table 72. BioMerieux SA Rubella Diagnostic Testing Product
 Table 73. BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 74. BioMerieux SA Recent Development
 Table 75. Cigna Company Details
 Table 76. Cigna Business Overview
 Table 77. Cigna Rubella Diagnostic Testing Product
 Table 78. Cigna Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 79. Cigna Recent Development
 Table 80. Diagnostic Laboratory of Oklahoma Company Details
 Table 81. Diagnostic Laboratory of Oklahoma Business Overview
 Table 82. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product
 Table 83. Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 84. Diagnostic Laboratory of Oklahoma Recent Development
 Table 85. GlaxoSmithKline Company Details
 Table 86. GlaxoSmithKline Business Overview
 Table 87. GlaxoSmithKline Rubella Diagnostic Testing Product
 Table 88. GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 89. GlaxoSmithKline Recent Development
 Table 90. HealthLink BC Company Details
 Table 91. HealthLink BC Business Overview
 Table 92. HealthLink BC Rubella Diagnostic Testing Product
 Table 93. HealthLink BC Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 94. HealthLink BC Recent Development
 Table 95. Mayo Clinic Company Details
 Table 96. Mayo Clinic Business Overview
 Table 97. Mayo Clinic Rubella Diagnostic Testing Product
 Table 98. Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 99. Mayo Clinic Recent Development
 Table 100. Ortho Clinical Diagnostics Company Details
 Table 101. Ortho Clinical Diagnostics Business Overview
 Table 102. Ortho Clinical Diagnostics Rubella Diagnostic Testing Product
 Table 103. Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 104. Ortho Clinical Diagnostics Recent Development
 Table 105. True Health Company Details
 Table 106. True Health Business Overview
 Table 107. True Health Rubella Diagnostic Testing Product
 Table 108. True Health Revenue in Rubella Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 109. True Health Recent Development
 Table 110. Research Programs/Design for This Report
 Table 111. Key Data Information from Secondary Sources
 Table 112. Key Data Information from Primary Sources
 Table 113. Authors List of This Report


List of Figures
 Figure 1. Rubella Diagnostic Testing Picture
 Figure 2. Global Rubella Diagnostic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rubella Diagnostic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Flow Cytometry Features
 Figure 5. Latex Slide Agglutination Test Features
 Figure 6. Monoclonal Antibodies Features
 Figure 7. Immunoassays Features
 Figure 8. Serological Testing Features
 Figure 9. Clinical Evaluation Features
 Figure 10. Global Rubella Diagnostic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Rubella Diagnostic Testing Market Share by Application: 2024 VS 2031
 Figure 12. Hospitals Case Studies
 Figure 13. Commercial Case Studies
 Figure 14. Physician Offices Case Studies
 Figure 15. Public Health Labs Case Studies
 Figure 16. Other Case Studies
 Figure 17. Rubella Diagnostic Testing Report Years Considered
 Figure 18. Global Rubella Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Rubella Diagnostic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Rubella Diagnostic Testing Market Share by Region: 2024 VS 2031
 Figure 21. Global Rubella Diagnostic Testing Market Share by Players in 2024
 Figure 22. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Rubella Diagnostic Testing Revenue in 2024
 Figure 24. North America Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Rubella Diagnostic Testing Market Share by Country (2020-2031)
 Figure 26. United States Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Rubella Diagnostic Testing Market Share by Country (2020-2031)
 Figure 30. Germany Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Rubella Diagnostic Testing Market Share by Region (2020-2031)
 Figure 38. China Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Rubella Diagnostic Testing Market Share by Country (2020-2031)
 Figure 46. Mexico Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Rubella Diagnostic Testing Market Share by Country (2020-2031)
 Figure 50. Turkey Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Rubella Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Abbott Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 54. Beckman Coulter Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 55. Bio Rad Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 56. Biogate Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 57. BioMerieux SA Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 58. Cigna Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 59. Diagnostic Laboratory of Oklahoma Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 60. GlaxoSmithKline Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 61. HealthLink BC Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 62. Mayo Clinic Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 63. Ortho Clinical Diagnostics Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 64. True Health Revenue Growth Rate in Rubella Diagnostic Testing Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4U20267
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-16R16865
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3F17301
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4B20221
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions